CALABRESE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 6.037
EU - Europa 4.805
AS - Asia 1.896
AF - Africa 323
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 13.077
Nazione #
US - Stati Uniti d'America 6.024
GB - Regno Unito 1.180
IT - Italia 1.002
SE - Svezia 706
DE - Germania 615
CN - Cina 540
VN - Vietnam 531
SG - Singapore 404
UA - Ucraina 311
IN - India 269
IE - Irlanda 233
FR - Francia 169
RU - Federazione Russa 159
CH - Svizzera 149
TG - Togo 134
ZA - Sudafrica 83
JO - Giordania 81
EE - Estonia 76
CI - Costa d'Avorio 68
BG - Bulgaria 63
BE - Belgio 33
FI - Finlandia 28
IR - Iran 19
SC - Seychelles 19
NG - Nigeria 18
RO - Romania 18
JP - Giappone 17
GR - Grecia 15
NL - Olanda 15
CA - Canada 12
PL - Polonia 7
AT - Austria 6
BR - Brasile 6
CZ - Repubblica Ceca 5
KR - Corea 5
TR - Turchia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
ES - Italia 4
HR - Croazia 4
LB - Libano 4
UZ - Uzbekistan 4
AU - Australia 3
HK - Hong Kong 3
PT - Portogallo 3
CL - Cile 2
IL - Israele 2
MY - Malesia 2
QA - Qatar 2
SA - Arabia Saudita 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
HU - Ungheria 1
ID - Indonesia 1
LK - Sri Lanka 1
MU - Mauritius 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
Totale 13.077
Città #
Southend 1.047
Fairfield 708
Chandler 705
Ashburn 553
Wilmington 353
Singapore 336
Woodbridge 334
Seattle 303
Houston 298
Princeton 285
Ann Arbor 265
Cambridge 238
Dublin 233
Dong Ket 223
Jacksonville 195
Bern 136
Lomé 134
Bologna 119
Nanjing 110
Westminster 102
Padova 99
Berlin 85
Amman 81
Milan 79
Abidjan 68
Turin 67
Sofia 63
New York 62
San Diego 62
Santa Clara 59
Saint Petersburg 55
Jinan 51
Beijing 50
Shenyang 49
Mülheim 45
Rome 43
Changsha 32
Brussels 31
Nanchang 31
Bremen 30
Hebei 29
Medford 28
Des Moines 27
Redmond 26
Boardman 23
Helsinki 23
Washington 23
Redwood City 22
Tianjin 19
Jiaxing 18
Mahé 18
Abeokuta 17
Taizhou 17
Dearborn 16
Olalla 16
Tokyo 16
Haikou 15
Leawood 15
Norwalk 15
Zhengzhou 15
Taiyuan 14
Los Angeles 13
Ningbo 13
Pesaro 13
Ferrara 12
Florence 12
Frankfurt am Main 12
London 12
San Venanzo 12
Boydton 11
Guangzhou 11
Phoenix 11
Verona 11
Bühl 10
Capaccio 10
Castel Maggiore 10
Falls Church 10
Kunming 10
Naples 10
Cervia 9
Genoa 9
Lanzhou 9
Toronto 9
Catania 8
Pune 8
Castelnuovo Rangone 7
Napoli 7
Amsterdam 6
Costa Mesa 6
Mumbai 6
Bari 5
Cesenatico 5
Dallas 5
Frankfurt Am Main 5
Genzano Di Roma 5
Hangzhou 5
Kuban 5
Modena 5
Monmouth Junction 5
Paris 5
Totale 8.568
Nome #
Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. 350
Ulcerative Colitis 209
COVID-19 in IBD: The experience of a single tertiary IBD center 203
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 190
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 160
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 155
Attachment and quality of life in patients with inflammatory bowel disease 155
Erosions or not in GORD? The potential role of oesophageal cell proliferation 152
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 149
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 148
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 147
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 146
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 145
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 144
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 142
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 141
Clinical course of microscopic colitis in a single-center cohort study 140
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. 137
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 136
Acute Esophageal Necrosis. 136
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 136
Differential activity and expression of superoxide dismutase in human gastric neoplasm 135
Endoscopic appearance of GERD: Putative role of cell proliferation 135
Management and treatment of distal ulcerative colitis 135
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 134
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 133
Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? 130
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 130
High-dose probiotics for the treatment of active pouchitis 129
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 129
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 129
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 125
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 125
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 124
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 124
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 124
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 121
Antibiotics and probiotics in treatment of inflammatory bowel disease 121
Oral budesonide in the treatment of chronic refractory pouchitis. 120
Identification of mobile lipids in human cancer tissues by ex vivo diffusion edited HR-MAS MRS 120
Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1. 118
Ex vivo HR-MAS Magnetic Resonance Spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa 117
Burden of illness in Italian patients with gastro-oesophageal reflux disease 117
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 117
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 116
Implications of antioxidant enzymes in human gastric neoplasms 114
Mesalazine with or without cholestyramine in the treatment of microscopic colitis: Randomized controlled trial 113
Role of conventional therapies in the era of biological treatment in Crohn's disease. 113
Long-term management of GERD in the elderly with pantoprazole 112
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 111
The role of Budesonide-MMX in active ulcerative colitis. 111
Oral beclomethasone dipropionate in chronic refractory pouchitis 110
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 110
Which therapies are advisable in pouchitis? 109
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 109
Discrimination of Healthy and Neoplastic Human Colon Tissues by ex Vivo HR-MAS NMR Spectroscopy and Chemometric Analyses 107
Probiotics, Prebiotics, and Antibiotics in IBD 106
Probiotics in IBD: A critical review 105
Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. 103
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 103
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 103
Pre-pouch ileitis 102
Erosions or not in GERD? The potential role of esophageal cell kinetics 102
Cytochrome P450 (CYP1A/1A2)and SODs expression in human gastric neoplasm 101
Role of Biologics in refractory pouchitis 101
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 101
Colitis evolving into ulcerative colitis 101
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation 101
THE ROLE OF SOD, CAT AND CYP1A1/1A2 IN HUMAN GASTRIC NEOPLASM   100
Cytochrome P450 (CYP 1A1/1A2) expression and lipid profile in human gastric neoplasm 100
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 100
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 100
Cytochrome P450 (CYP 1A1/1A2) and SODs expression in human gastric neoplasm 97
Rescue therapy: ciclosporin or infliximab? 97
Bifidobacteriaceae usually colonize human hypochloridric stomach 96
Molecular characterization of human gastric mucosa by HR-MAS magnetic resonance spectroscopy 93
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 93
The role of antibiotics and probiotics in pouchitis 92
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 92
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 90
Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis 88
Cancer surveillance in ulcerative colitis: Critical analysis of long-term prospective programme 87
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 86
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 86
Inflammatory bowel diseases and spondyloarthropathies 85
null 84
Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach 83
null 83
Implications of antioxidant protein in human gastric neoplasm 81
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 80
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 78
Timing and protocols of clinical and endoscopic surveillance of Barrett's esophagus 77
Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR Spectroscopy and chemometric analyses. 76
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 76
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 74
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 71
Dilated intercellular spaces as a marker of oesophageal damage: Comparative results in gastro-oesophageal reflux disease with or without bile reflux 71
Risk of duodenal cancer in patients with familial adenomatous polyposis 69
EFFICACY, SAFETY, IMPACT ON NATURAL HISTORY OF LONG TERM TREATMENT WITH THIOPURINES IN CROHN'S DISEASE PATIENTS. A SINGLE CENTER EXPERIENCE 68
Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis 68
Totale 11.598
Categoria #
all - tutte 34.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.442 0 0 49 190 274 306 331 387 392 210 132 171
2020/20211.965 362 86 36 98 58 83 49 107 210 130 85 661
2021/20222.611 210 88 182 181 251 140 66 172 103 193 628 397
2022/20233.153 286 454 156 375 219 254 109 168 577 59 233 263
2023/2024936 65 154 86 77 72 228 60 44 23 56 30 41
2024/2025674 183 410 81 0 0 0 0 0 0 0 0 0
Totale 13.421